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Abstract
Littleresearchhasbeendoneontheuseofantidepressantsamonghomeboundolder
adults,especiallylow-incomehomeboundolderadults,andtheirperceptionsofthe
effectiveness of their medication. The purposes of this study were to examine self-
reported use of antidepressants among depressed homebound older adults, class
and type of antidepressants used, individual-level correlates of antidepressant use,
and users’ perceptions of the effectiveness of antidepressants. Data on self-reported
useofantidepressantswereobtainedaspartofafeasibilitystudyofshort-termtele-
health problem-solving therapy for depressed low-income homebound adults (n =
162) aged 50 or older. The 24-item Hamilton Rating Scale for Depression (HAMD)
wasusedtoassessdepressionseverity.Theﬁndingsshowthatabouthalfofthestudy
participants were taking antidepressants, with 26.6% of those on antidepressants
rating their medications very effective and 21.5% rating them effective. Female
gender was positively, but older age and being Black/African American were neg-
atively associated with the likelihood of antidepressant use. Perceived effectiveness
of antidepressants was negatively associated with older age and the HAMD score.
The ﬁndings suggest that personalized approaches to depression management may
be needed in subgroups of depressed older adults, including culturally tailored
medication counseling in Black/African-American older adults.
Introduction
Homeboundolderadultsaremorelikelythantheirmobility-
unimpairedpeerstosufferfromdepression.Onestudyfound
that 13.5% of 539 of a visiting nurse agency’s homecare
clients, aged 65 or older, were diagnosed with major de-
pressive disorder (MDD), a rate twice as high as was found
in those receiving ambulatory care; it also found that 71%
of those who were depressed were experiencing their ﬁrst
episodeofdepression(Bruceetal.2002).Otherstudiesfound
10–12%ratesofclinicallysigniﬁcantdepressivesymptoms—
ascoreof10orhigheronthePatientHealthQuestionnaire-9
(PHQ-9)—among homebound older adults (Ell et al. 2005;
Sireyetal.2008).Whenyoungeragegroups(50–64)ofhome-
bound adults were included, 17.5% had clinically signiﬁcant
depressivesymptoms(PHQ-9≥10),and8.8%hadprobable
MDD (Choi et al. 2010).
Older adults with greater medical burden and functional
impairment are more vulnerable to depression, and depres-
sion can lead to further exacerbation of physical, functional,
and mental health problems (Charlson and Peterson 2002;
Taylor et al. 2004; Alexopoulos 2005; Covinsky et al. 2010;
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Pinquart and Duberstein 2010; Celano and Huffman 2011).
Higher rates of depression in homebound older adults than
in their ambulatory age peers are likely to stem from stresses
associated with their chronic illnesses and disability. Among
low-income homebound older adults, ﬁnancial worries and
socialisolationcreatedbytheirhomeboundstateaswellasby
the stresses that arise from managing chronic illnesses were
found to increase their vulnerability to depression (Choi and
McDougall 2007). For a large proportion of low-income, de-
pressed, homebound older adults, their depression may also
be a continuation of poor mental health that they have expe-
rienced for many years, associated with long-term economic
adversities,poorphysicalhealth,andfamily/relationshipcon-
ﬂicts(Rushetal.2005;Qiuetal.2010).Despitetheirsuffering
from depression, low-income, depressed, homebound older
adults face signiﬁcant barriers to accessing treatment in gen-
eralandpsychotherapyinparticular,duetotheirhomebound
state and lack of ﬁnancial resources (Choi and McDougall
2007; Qiu et al. 2010). The most common depression treat-
ment for them tends to be antidepressant medication pre-
scribed by their primary care or family physician (PCP)
(Crystal et al. 2003; Weissman et al. 2011). Previous stud-
iesalsofoundthatPCPsdidnotroutinelyreferolderpatients
to a psychiatrist or psychotherapist, that they were skeptical
about the effectiveness of psychotherapy, that they took re-
sponsibility for diagnosing and treating depression in their
older patients mostly with selective serotonin reuptake in-
hibitors (SSRIs) as ﬁrst-line agents, and that they reported
their conﬁdence in prescribing antidepressants as high or
very high (Gallo et al. 1999; Fischer et al. 2003; Wang et al.
2006). However, there is a paucity of research on the class
andtypeofantidepressantsthatdepressedhomeboundolder
adults, especially those with low income, are taking and on
theirperceptionsoftheeffectivenessoftheirmedication.The
purposes of this study were to examine (1) the class and type
of antidepressants that low-income, depressed, homebound
olderadultsreportedthattheyweretaking;(2)theindividual-
level correlates of antidepressant use versus nonuse; and
(3) these older adults’ perceptions about the effective-
ness of antidepressants that they reported they had been
taking.
Conceptual Framework and Study
Hypothesis
The Andersen-Newman behavioral model of health services
use (Andersen 1995) provides the conceptual formulation
for understanding homebound older adults’ antidepressant
intake. This behavioral model suggests that people’s use of
health services is a function of their predisposition to use
services, of factors that enable or impede use, and of their
need for care. Among predisposing factors are demographic
characteristics (age and sex, which represent differences in
biology and in values and beliefs about illnesses and ac-
ceptable courses of treatment); social structure (a broad ar-
ray of factors, such as race/ethnicity and occupation, that
determine the status of a person in the community and
his/her ability and resources to cope with presenting prob-
lems); and health beliefs (attitudes, values, and knowledge,
culturally determined or otherwise, that people have about
health and health services). Enabling factors are at both per-
sonal(means/resourcesandknow-howtoaccessservicesthat
may be determined by education, income, health insurance,
and social support) and community (healthcare provider
and facility) levels. Need factors refer to the most imme-
diate reason(s) the services are needed: the illness- and/or
impairment-related conditions, perceived and/or evaluated,
for which the services are sought.
In the present study, we examined the inﬂuence of sex,
age,andrace/ethnicityaspredisposingfactors.Sexislikelyto
play a role in antidepressant use, as older men are less likely
than their female counterparts to admit their depression and
seek treatment (Hinton et al. 2006). With regard to age and
racial/ethnic difference, based on data from older Medicare
beneﬁciaries with a diagnosis of depression, Crystal et al.
(2003) found that those aged 75 or older and of “Hispanic
and other ethnicity” were signiﬁcantly less likely than those
aged 65–69 and non-Hispanic Whites to receive either an-
tidepressants or psychotherapy. Weissman et al. (2011) also
found that, controlling for depression, Black homecare older
adults(aged65orolder)werelesslikelythanWhitehomecare
older adults to use any antidepressant. One study (Cooper
et al. 2003) found that Black and Hispanic adults of mixed
agegroupshadlowerodds thanWhiteadultsofthesameage
groups ﬁnding antidepressant medications acceptable, while
othersdidnotﬁndanyracial/ethnicdifferenceinolderadults’
preference for depression treatment modality (Landreville
etal.2001;Gumetal.2006;ChoiandMorrow–Howell2007).
As for enabling factors, in addition to the level of ed-
ucation, income, private or veterans insurance or medical
assistance program (MAP) coverage, and family support, we
examined the question of whether the level of older adults’
disability were associated with their use of antidepressant
medication. Low-income homebound older adults are un-
likely to seek and use treatment for their depression when
managing their more-pressing disability and chronic medi-
calconditionsaswellaspayingforandtakingmedicationfor
these conditions (Proctor et al. 2008). Having to take multi-
plemedicationsformultiplemedicalproblemsmayalsoraise
their concerns about medication-interaction effects (Choi
and Morrow–Howell 2007).
The primary need factor was the level of depressive symp-
toms.Inaddition,weexaminedtheintakeofantianxietyand
prescriptionpainmedicationsasneedfactors,giventhatanx-
ietyandpainmaysigniﬁcantlyincreasedepressivesymptoms
(Karp and Reynolds 2009; Lenze et al. 2001).
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These were the study hypotheses regarding antidepres-
sant use: among low-income, depressed, homebound older
adults, the likelihood of taking antidepressants would be
(H1a) negatively associated with male gender, older age, and
Black/African American and Hispanic race/ethnicity; (H1b)
positively associated with a higher level of education, in-
come, and family support, and with private or veterans (VA)
insuranceorMAPcoverage;(H1c)negativelyassociatedwith
a higher level of disability; and (H1d) positively associated
withahigherlevelofdepressivesymptoms,antianxietymed-
ication use, and pain medication use.
Our literature search did not ﬁnd any previous study that
examined depressed patients’ self-reported perception of ef-
fectiveness of antidepressants. Measuring patients’ percep-
tions of effectiveness is inherently difﬁcult, as those with
poor treatment response to pharmacotherapy tend to have a
higher incidence of noncompliance and treatment termina-
tion (Martin et al. 2009). Because of the absence of any pre-
vious research on patients’ perception of effectiveness and
also because of the small number of antidepressant users
who provided data on perceived effectiveness, we posited an
exploratoryhypothesisthattheusers’perceptionofeffective-
ness would be negatively associated with male gender, older
age,Black/AfricanAmericanandHispanicrace/ethnicity,and
a higher level of depressive symptoms.
Materials and Methods
Participants
The sample consisted of homebound adults, aged 50 or
older, who participated in a study that examined the feasibil-
ity of short-term, telehealth (videoconferencing) problem-
solving therapy. Consistent with the Medicare eligibility cri-
teria for receipt of home health services (Medicare Home
Health Independence 2005), homebound older adults are
deﬁnedinthisstudyasthosewho,due to medicalconditions
and/or mobility-affecting impairments, cannot freely leave
their home and require help in doing so.
Case managers at a large Meals on Wheels program and
other aging-service network agencies serving low-income,
homebound older adults in central Texas referred to the
project those who scored 5 or higher on the PHQ-9 or who
showed other signs of depression. Referred individuals were
administered the 24-item HAMD and DSM-IV diagnostic
interviews for depression. Those whose HAMD scores were
10 or higher were included in the parent study. The exclu-
sioncriteriawere(1)highsuiciderisk;(2)dementia(assessed
withtheMini-Cog[Borsonetal.2000]);(3)bipolardisorder;
(4) 12-month or lifetime psychotic symptoms or disorder;
(5) presence of co-occurring alcohol or other addictive sub-
stance abuse; and (6) current involvement in psychotherapy.
Of the 203 older adults who were referred and assessed for
eligibility, 165 met the inclusion criteria but three refused
to participate in the study and did not proceed to baseline
assessment.Asaresult,162whoprovideddataontheirphar-
macotherapy at baseline were included in this analysis. The
study was approved by the Institutional Review Board of the
University of Texas at Austin.
Measures
Antidepressant medication use, class, type
The names and doses of antidepressants that participants re-
ported they had been taking during the preceding 2 months
were collected from the original medication containers
and/or participant-provided lists of all medications taken.
These lists had been compiled by participants’ family mem-
bers, visiting nurses, case managers, PCPs, or as part of
their hospital/emergency department discharge summary.
The start date of each medication was also obtained from
the medication container, the medication list, and/or the
individual’s oral report. The project’s geriatric psychiatrist
member [MEK] reviewed each medication to see whether
the dose were therapeutic. This review process excluded low-
dose uses of tricyclic (i.e., 10 mg of amitriptyline; n = 4) and
atypical(i.e.,25–50mgoftrazodone;n=2)antidepressants.
Predisposing factors
Age was grouped into 50–59 years (reference category), 60–
69 years, and 70 years or older. Sex was female (=1) versus
male (=0), and race/ethnicity was non-Hispanic White (ref-
erence category), Black/African American, and Hispanic.
Enabling factors
Dichotomouscategorieswereusedtomeasurethelevelofed-
ucation(≤highschoolvs.≥somecollege)andfamilyincome
(≤$15,000 vs. >$15,000). The category, private or veterans
health insurance or MAP, referred to any type of employer-
provided, privately purchased, or VA health insurance or
MAP for low-income older or disabled adults that provides
subsidy for medication expenses. Family support was mea-
suredbythe6-itemfamilysupportscaleoftheLubbenSocial
Network Scale Expanded (LSNS-E) (Lubben and Gironda
2000), which has been frequently used to measure the size
of older adults’ social support networks and their perceived
a n da c t u a ll e v e l so fs o c i a ls u p p o r tf r o mt h e s en e t w o r k s .
Cronbach’s α for the study sample was .75.
Disability status was measured using the short form
(12-item) World Health Organization Disability Assessment
Schedule-II (WHODAS-II [Disability Assessment Schedule
2000]), which assesses the activity limitations and participa-
tionrestrictionsexperiencedbyanindividual.Itdoesnotask
respondents to identify whether the problem was caused by
medical or mental health conditions. In consideration of the
homebound state of the subjects, the last item, “Your day to
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day work,” was reworded to “Your day to day work in and
around the house.”
Need factors
Depressive symptoms were measured with the 24-item
HAMD. It consists of the GRID-HAMD-21 Structured In-
terviewGuide(2003)augmentedwiththreeadditionalitems
assessing feelings of hopelessness, helplessness, and worth-
lessness, with speciﬁc probes and follow-up questions devel-
oped by Moberg et al. (2001). Antianxiety medication and
pain medication data were collected from the original med-
ication containers and/or the individual’s list of all medica-
tions being taken.
Perceived effectiveness of antidepressants
Those taking any antidepressant medication were asked to
rate their perception of the effectiveness of each medication
on a 5-point scale (1 = not effective; 2 = a little effective;
3 = somewhat effective; 4 = effective; 5 = very effective).
Statistical Methods
Following univariate analysis of the participants’ character-
istics, including those of predisposing, enabling, and need
factors,wedescribedthesubjects’antidepressantusebymed-
icationclass,type,durationofintake,andperceivedeffective-
ness. Then, we used binary logistic regression analysis to test
the study hypotheses regarding self-reported antidepressant
use versus nonuse. For the subset of participants who used
antidepressants and provided data on perceived effectiveness
(n = 65), we used ordinary least squares (OLS) regression
analysis to test the exploratory hypothesis regarding the re-
lationship between the perceived effectiveness and the pre-
disposing factors and the HAMD scores. Bivariate analysis
showedthattheeffectivenessperceptionwasnotsigniﬁcantly
correlated with any enabling factor and other participant
characteristics (e.g., pain frequency and intensity).
Results
Participant characteristics
Table 1 shows that 56.2% of the participants were Black/
African American or Hispanic and 69.8% had family income
less than or equal to $15,000. The mean WHODAS-II score,
35.84 ± 9.03, indicates a high level of disability. The mean
HAMDscorewas23.56±7.72,and63.6%hadMDD.Nearly
half(48.8%)oftheparticipantsreportedthattheyweretaking
at least one antidepressant medication. A majority (86.4%)
reported that they were experiencing chronic pain, with the
mean self-reported frequency of 8.66 ± 2.09 and the mean
self-reported intensity of 7.69 ± 2.20 on a 10-point scale;
33.3% and 56% reported that they were taking antianxiety
and prescription pain medications, respectively.
Table 1. Participant characteristics (N = 162).
Sex, n (%) male 38(23.5)
Female 124(76.5)
Age (year) mean ± SD 65.10 ± 9.57
Range 50–89
Age group, n (%)
50–59 53(32.7)
60–69 61(37.7)
70–79 32(19.8)
80+ 16(9.9)
Race/ethnicity, n (%)
Non-Hispanic White 71(43.8)
Blacks/African American 54(33.3)
Hispanic 37(22.8)
Education, n (%)
<High school 14(8.6)
Some high school 23(14.2)
GED or high school graduate 31(19.1)
Some college 59(36.4)
2–4 year college graduate 22(13.6)
Graduate school attendance or completion 13(8.0)
Family income, n (%)
≤$15,000 113(69.8)
>$15,000 49(30.2)
Family support (LSNS-E)
1
Mean ± SD 15.77 ± 6.20
Median 17
Range 0–28
Health insurance, n (%)
Medicare 129(79.6)
Medicaid 51(31.5)
Private/VA insurance or MAP 67(41.4)
No insurance 4(2.5)
Disability score (WHODAS-II)
2
Mean ± SD 35.84 ± 9.03
Median 36
Range 13–56
24-item HAMD score
Mean ± SD 23.56 ± 7.72
Median 22.5
Range 10–42
Depression diagnosis, n (%)
Major depressive disorder 103(63.6)
Depressive disorder-NOS 53(32.7)
Dysthymic disorder 6(3.7)
Antidepressant medication currently taking, n (%)
Yes, have been taking 79(48.8)
No, have not been taking 83(51.2)
Antianxiety medication, currently taking, n (%)
Yes, have been taking 58(35.8)
No, have not been taking 104(64.2)
Antidepressant/antianxiety medications, n (%)
Neither 64(39.5)
Antidepressant only 40(24.7)
Antianxiety only 19(11.7)
Both antidepressant and antianxiety 39(24.1)
Chronic physical pain during the past 3 months, n (%)
Yes, have had pain 140(86.4)
No, have not had pain 22(13.6)
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Table 1. Continue
Frequency of chronic pain (n = 140, n [%])
3
Mean ± SD 8.66 ± 2.09
Median 10
Intensity of chronic pain (n = 140, n [%])
4
Mean ± SD 7.69 ± 2.20
Median 10
Prescription pain medication currently taking, n (%)
Yes, have been taking
No, have not been taking
1Lubben Social Network Scale-Expanded family scale: scores of 0 and 30
represent no family support and full family support, respectively.
2World Health Organization Disability Assessment Schedule-II: scores
of 12 and 60 represent no disability and extremely severe disability,
respectively.
3Measured on a 10-point scale (1 = once a week or less often; 10 = all
the time).
4Measured on a 10-point scale (1 = minimal; 10 = extreme).
The high rates of chronic pain experience and pain medi-
cation use among these depressed older adults are notable.
Further analysis (not shown in Table 1) found no signiﬁcant
difference in HAMD scores by sex, age, race/ethnicity, edu-
cation, income, and family support; by presence or absence,
frequency,andintensityofchronicpain;orbyantidepressant,
antianxiety, and pain medication intake status.
Self-reported antidepressant use and
perceived effectiveness
Table 2 shows that of the 79 participants who reported that
they were taking antidepressants, only 7.6% (n = 6) were
taking two medications. Of those taking one antidepressant,
65.8%(n=48)weretakinganSSRI,31.5%(n=23)weretak-
ing a serotonin-norepinephrine reuptake inhibitor (SNRI),
and 2.7% (n = 2) were taking an atypical antidepressant
(bupropion[Wellbutrin]).OftheSSRIs,citalopram(Celaxa)
and sertraline (Zoloft) were most frequently taken, and of
the SNRIs, duloxetine (Cymbalta) was the most frequently
taken. Of the participants who provided data on the dura-
tion of their antidepressant intake, the median duration was
2.01 years. Further analysis found that all six participants
who reported that they had been taking two antidepressants
wereaged60–69andhadatleastsomecollegeeducation;ﬁve
were women; four were non-Hispanic White and two were
Hispanic; and ﬁve had annual income less than or equal to
$15,000. They also had signiﬁcantly higher HAMD scores
than those taking just one antidepressant (31.0 ± 5.72 vs.
22.86± 7.21, P = 0.009), but did not differ in their disability
score.
Table 2 also shows that 48.1% of the self-reported an-
tidepressant users rated their medications as very effective
or effective and that 26.6% rated them as somewhat effec-
tive. Fourteen participants, or 17.7%, stated that either (1)
Table 2 Antidepressant class, types, duration of intake, and perceived
effectiveness (N = 79).
No. of antidepressant medication currently taking, n (%)
One 73 (92.4)
Two 6 (7.6)
Those taking one antidepressant, n
Selective serotonin reuptake inhibitors (SSRIs) 48
Citalopram 14
Escitalopram 9
Fluoxetine 5
Paroxetine 3
Sertraline 17
Serotonin-norepinephrine reuptake inhibitors (SNRIs) 23
Duloxetine 13
Mirtazapine 2
Venlafaxine 8
Atypical 2
Buproprion 2
Those taking two antidepressants, n
Citalopram + duloxetine 1
Citalopram + buproprion 2
Fluoxetin + duloxetine 1
Fluoxetin + venlafaxine 1
Mirtazapine + buproprion 1
Duration of antidepressant intake (n = 66; year)
1
Mean 3.69 ± 4.83
Median 2.01
Range 0.2–25.14
Perceived effectiveness of antidepressants, n (%)
Very effective 21 (26.6)
Effective 17 (21.5)
Somewhat effective 21 (26.6)
A little effective 5 (6.3)
Not effective 1 (1.3)
Do not yet know/cannot tell without getting off 14 (17.7)
1Thirteen subjects could not recall when they had begun taking antide-
pressants.
they did not yet know whether their medications were effec-
tive because they had been taking them for a short time (2–
3 months) or (2) they were unable to tell without getting off
the medication because they had been taking it for a long
time.Dataonparticipants’historyofpharmacotherapywere
not systematically collected, but a few participants who had
not been taking antidepressants in the preceding 2 months
volunteeredthattheyhadstoppedtakingmedicationbecause
of no perceived beneﬁts and/or side effects, and one partici-
pant volunteered that she had not ﬁlled the prescription.
Correlates of antidepressant use and
perceived effectiveness
Table 3 shows that antidepressant use was signiﬁcantly as-
sociated with all three predisposing factors. Being female
was positively associated with antidepressant use. However,
being aged 70 or older, as opposed to aged 50–59, and be-
ing Black/African American, as opposed to non-Hispanic
White,werenegativelyassociatedwithantidepressantuse.Of
enabling factors, low income (i.e., ≤$15,000) was negatively
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Table 3. Correlates of antidepressant intake: binary logistic regression results (N = 162).
Variable B (SE) Odds ratio (95% CI)
Sex
Female 1.10 (0.50)
∗ 3.0 (1.12–8.05)
(Male)
Age group
(50–59)
60–69 −0.56 (0.49) 0.57 (0.22–1.48)
70+ −1.61 (0.55)
∗∗ 0.20 (0.07–0.59)
Race/ethnicity
(Non-Hispanic White)
Black/African American −1.85 (0.49)
∗∗∗ 0.16 (0.06–0.41)
Hispanic −0.36 (0.49) 0.70 (0.27–1.81)
Education
High school or lower 0.37 (0.42) 1.45 (0.63–3.33)
(at least some college)
Income
≤$15,000 −0.10 (0.45)
∗ 0.37 (0.15–0.92)
(>$15,000)
Private/veterans insurance or MAP
Yes 0.55 (0.41) 1.72 (0.77–3.87)
(No)
Family support score 0.02 (0.03) 0.98 (0.92–1.05)
Disability score (WHODAS-II) 0.01 (0.03) 1.01 (0.96–1.06)
24-item HAMD score −0.02 (0.03) 0.98 (0.93–1.03)
Antianxiety medication
Yes 1.28 (0.41)
∗∗ 3.59 (1.60–8.07)
(No)
Prescription pain medication
Yes 0.53 (0.41) 1.70 (0.76–3.80)
(No)
Cox & Snell R
2 0.27
Nagelkerke R
2 0.37
−2 log-likelihood model χ
2 (df, P) 172.72 (13; P < 0.001)
∗∗∗P < 0.001;
∗∗P < 0.01;
∗P < 0.05.
associatedwithantidepressantuse,butthelevelofeducation,
private/veteransinsuranceorMAPcoverage,familysupport,
and disability score were not signiﬁcant factors. Of need fac-
tors, the HAMD score and pain medication intake were not
signiﬁcantly associated with antidepressant use but antianx-
iety medication intake was a signiﬁcant factor.
The OLS regression results (not shown in Table 3) found
that the perceived effectiveness of antidepressants was nega-
tively associated with being aged 70 or older (β =− 0.321,
t =− 2.210, P = 0.031) and the HAMD score (β =− 0.299,
t =− 2.320, P = 0.024). Sex and race/ethnicity were not
signiﬁcant correlates. However, caution is required in inter-
preting the results, given the small sample size.
Discussion
The study found that about half of the low-income, de-
pressed, homebound older-adult participants were taking
antidepressant medications. All predisposing factors (sex,
age, and race/ethnicity) were signiﬁcantly associated with
the likelihood of antidepressant use, supporting H1a. Of the
enabling factors, only income was a signiﬁcant correlate. Of
theneedfactors,severityofcurrentdepressivesymptomswas
notsigniﬁcantlyassociatedwithantidepressantintake,partly
because the study included only depressed participants. The
cross-sectional data did not allow us to examine the severity
of depressive symptoms prior to antidepressant use either.
However, the ﬁnding that self-reported use of antianxiety
medication was positively associated with self-reported an-
tidepressant use suggests the importance of comorbid anx-
iety and depression and associated symptom severity as a
need factor. Thus, the logistic regression results did not sup-
port H1c and only partially supported H1b and H1d. The
hypothesis regarding the factors associated with the partici-
pants’ perception of effectiveness of antidepressants was also
partially supported as it was negatively associated with older
age (70+) and higher HAMD scores, but it was not signiﬁ-
cantly associated with gender and race/ethnicity.
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The negative relationship between age and antidepressant
use appears to suggest an age cohort effect, with those aged
70orolderhavingamorenegativepredispositiontowardan-
tidepressant use than those aged 50–59. Based on the study’s
ﬁnding that those aged 70 or older were also less likely to
perceive their medications to be effective, some individuals
in this age group may have stopped taking antidepressants.
PCPs may also be reluctant to prescribe antidepressants to
older patients, especially those with multiple medical con-
ditions (Bruce et al. 2002; Ayalon et al. 2010). The ﬁnding
may also reﬂect low-income, depressed, homebound older
adults’ preference for nonpharmacological over pharmaco-
logical treatment.
The negative relationship between being Black/African
American and using antidepressants conﬁrms the ﬁndings
of previous research. Studies have found that in general,
racial/ethnic minority older adults were less likely than their
non-Hispanic White peers to use formal mental health ser-
vices, but more likely to use traditional self-care regimens
and prayer and to turn to their informal support net-
works and to clergy (Snowden 2001). These racial/ethnic
differences in help-seeking behaviors may be due in part
to cultural differences in the way a person’s symptoms
are manifested, deﬁned, interpreted, and labeled and in
the person’s attitudes, values, and knowledge about neg-
ative aspects or perceived barriers (i.e., side effects, ex-
pense, inconvenience) of pharmacotherapy (Andersen 1995;
Lewis–Fernandez and Diaz 2002). Interestingly, though, our
ﬁndings show that Hispanic older adults did not differ
from their non-Hispanic peers in their likelihood of taking
antidepressants.
The ﬁndings also show that the participants’ perception
of effectiveness of antidepressants tended to match their de-
pressive symptoms, as those with higher HAMD scores re-
ported lower effectiveness ratings. Although those aged 70
or older also reported lower effectiveness ratings, sex and
race/ethnicitywere not signiﬁcantpredictors of perceived ef-
fectiveness of antidepressants. This suggests that a majority
of the current users, regardless of sex and race/ethnicity, per-
ceive the medication as being at least somewhat effective.
However,asthosewhohadbeendissatisﬁedwithantidepres-
sant use were likely to have stopped using them, this ﬁnding
needs to be interpreted with caution.
In many efﬁcacy trials of antidepressants in the treatment
of late-life depression, antidepressants were more effective
thanplacebos,andnodifferencewasfoundinantidepressant
class outcomes among older adults with major depression
or nonspeciﬁc depression severity, although SSRIs may be
better tolerated than tricyclics (Roose and Schatzberg 2005;
Reynolds et al. 2006). However, a meta-analysis of the use
of second-generation antidepressants in late life found their
effects tend to be modest (Nelson et al. 2008). A previous
study also suggested that older adults with the greatest co-
morbidity may be at high risk for poor depression treatment
outcomes (Kales and Valenstein 2005), while another study
found that antidepressants are effective in depressed patients
with a range of comorbid physical conditions (Sheikh et al.
2004).
Despitethegenerallypositiveperceptionofeffectivenessof
antidepressants among the study participants who had been
taking the medications for at least 8 weeks (and some for
a much longer period), the continuing depression—either
nonremitted or in partial remission—of all of them suggests
that their care may not have been well monitored by the
prescribing clinician. This ﬁnding is consistent with those
of previous research, namely, that depression among home-
bound older adults is not treated well although it is more
likely to be identiﬁed and treated than it once was (Bruce
et al. 2002; Ayalon et al. 2010).
This study has several limitations. First, the sample size is
relatively small. Second, despite the participants’ self-reports
that they were taking the medications, actual medication ad-
herence was not known. Third, lack of data on a medication
reconciliation with prescribers is also a limitation. Fourth,
we did not systematically collect data from those who were
not taking antidepressants to learn whether they had been
offered or had stopped taking them and why. Future research
is needed to examine the relationship between patients’ per-
ception of effectiveness and medication adherence. Despite
these limitations, the present study provides insights into
these older adults’ perceptions of the effectiveness of antide-
pressants.
Conclusion
The ﬁndings of this study suggest that tailored approaches
to depression management may be necessary in homebound
olderadults,especiallyoldermen,thoseaged70orolder,and
racial/ethnic minorities. Those who suffer from depression
but do not take antidepressants may be better encouraged
to take them if they receive more individualized attention
from a clinic staff member or a care manager who can check
on them to discuss their depression care. In addition, there
may be a need for culturally tailored medication counsel-
ing of Black/African-American older adults to improve their
uptake rate. Althoughpredisposing factors were signiﬁcantly
associated with self-reported antidepressant use, it appears
that they were not signiﬁcantly associated with perceived ef-
fectiveness of antidepressants. Given low-income, depressed,
homebound older adults’ multiple physical, functional, and
mental health problems, future research also needs to exam-
ine if these older adults may want to combine antidepressant
treatment with psychotherapeutic and/or case management
approaches.
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